Key result
Moderate or severe pulmonary hypertension independently predicted 3-year major cardiovascular events in AMI patients after PCI, with event rates of 39.3% and 68.4% respectively, compared to 18.9% in those with normal RVSP.
Why the study?
The role of pulmonary hypertension in long-term clinical outcomes was unclear in patients with acute myocardial infarction, and the significance of elevated RVSP on echocardiography is often underestimated.
Does elevated right ventricular systolic pressure (pulmonary hypertension) predict major adverse cardiac events in patients with acute myocardial infarction after successful percutaneous coronary intervention?
Cohort (n=2,526)
Yes
Does elevated right ventricular systolic pressure (pulmonary hypertension) predict major adverse cardiac events in patients with acute myocardial infarction after successful percutaneous coronary intervention?
Answers are grounded in this paper and cite their sources.
Elevated right ventricular systolic pressure (moderate or severe pulmonary hypertension) on routine pre-discharge echocardiography is an independent predictor of long-term major adverse cardiac events in patients with acute myocardial infarction following successful PCI.
Background/Aims: Pulmonary hypertension (PH) in patients with heart failure contributes to a poor prognosis. However, the role of PH in the long-term clinical outcome is unclear in those with acute myocardial infarction (AMI). The clinical significance of elevated right ventricular systolic pressure (RVSP) on routine echocardiography is underestimated.Methods: This study enrolled 2,526 AMI patients (65.1 ± 12.7 years; 1,757 males [69.6%]) from the Korean AMI registry who underwent successful percutaneous coronary intervention and pre-discharge transthoracic echocardiography (TTE). The patients were divided into four groups according to the RVSP on TTE: normal RVSP (RVSP < 35 mmHg, n = 1,695), mild PH (35 ≤ RVSP < 45 mmHg, n = 601), moderate PH (45 ≤ RVSP < 70 mmHg, n = 211), and severe PH (RVSP ≥ 70 mmHg, n = 19). Major adverse cardiac events (MACE) were compared among the four groups.Results: During the 3-year clinical follow-up period, MACE occurred in 562 patients (22.2%), including 321 (18.9%), 145 (24.1%), 83 (39.3%), and 13 patients (68.4%) in the normal RVSP and mild, moderate, and severe PH groups, respectively. On multivariate analysis, independent factors for MACE were moderate or severe PH, age ≥ 65 years, Killip class ≥ III, left ventricular ejection fraction < 40%, hypertension, and diabetes.Conclusions: Measuring RVSP is useful for stratifying the risk of patients with AMI; MACE occurred in patients with moderate or severe PH.
No takes yet. Share an insight, caveat, or question.
Cho et al. (2022) conducted a cohort in Acute myocardial infarction (n=2,526). Pulmonary hypertension (elevated RVSP) vs. Normal RVSP (< 35 mmHg) was evaluated on Major adverse cardiac events (MACE). Moderate or severe pulmonary hypertension independently predicted 3-year major cardiovascular events in AMI patients after PCI, with event rates of 39.3% and 68.4% respectively, compared to 18.9% in those with normal RVSP.
Synapse has enriched 10 related papers. Consider them for comparative context: